Telomerase activity and in situ telomerase RNA expression in malignant and non-malignant lymph nodes.

Por Yashima, K, Piatyszek, M A, Saboorian, H M, Virmani, A K, Brown, D, Shay, J W, Gazdar, A F
Publicado em 1997

Isolation of human anti-c-erb B-2 Fabs from a lymph node-derived phage display library

Por CLARK, M A, HAWKINS, N J, PAPAIOANNOU, A, FIDDES, R J, WARD, R L
Publicado em 1997

Comparative migration of T- and B-lymphocyte subpopulations into skin inflammatory sites.

Por van Dinther-Janssen, A C, van Maarsseveen, A C, de Groot, J, Scheper, R J
Publicado em 1983

Preclinical Evaluation of Robotic-Assisted Sentinel Lymph Node Fluorescence Imaging

Por Liss, Michael A., Farshchi-Heydari, Salman, Qin, Zhengtao, Hickey, Sean A., Hall, David J., Kane, Christopher J., Vera, David R.
Publicado no J Nucl Med (2014)

A comparative study of nuclear form factor, area and diameter in non-Hodgkin's lymphomas and reactive lymph nodes.

Por Crocker, J, Jones, E L, Curran, R C
Publicado em 1983

Lung T-cell subset composition at the time of surgical resection is a prognostic indicator in non-small cell lung cancer

Por Zikos, T. A., Donnenberg, A. D., Landreneau, R. J., Luketich, J. D., Donnenberg, V. S.
Publicado em 2011

Duodenal gangliocytic paraganglioma with lymph node metastases: A case report and comparative review of 31 cases

Por Cathcart, Sahara J, Sasson, Aaron R, Kozel, Jessica A, Oliveto, Jennifer M, Ly, Quan P
Publicado no World J Clin Cases (2017)

Detection of metastases in sentinel lymph nodes of breast cancer patients by multiple mRNA markers

Por Weigelt, B, Verduijn, P, Bosma, A J, Rutgers, E J, Peterse, H L, van't Veer, L J
Publicado em 2004

Lymph node staging in non-small cell lung cancer: evaluation by [18F]FDG positron emission tomography (PET)

Por Guhlmann, A., Storck, M., Kotzerke, J., Moog, F., Sunder-Plassmann, L., Reske, S. N.
Publicado em 1997

Comparative efficacy of positron emission tomography with FDG and computed tomographic scanning in preoperative staging of non-small cell lung cancer.

Por Gupta, N C, Graeber, G M, Rogers, J S, Bishop, H A
Publicado em 1999

Cardiovascular risk determination: discrepancy between total cholesterol evaluation and two compound laboratory indices in Norway.

Por Berg, J E, Høstmark, A T
Publicado em 1994

Reducing perceived pain levels during non-breast lymphoscintigraphy

Por Johnston, M.J., Ntambi, J.A., Hilliard, N., Spencer, H.J., Vaughn, R., Owens, S.S., Myrick, R.S., Parker, L.D., Garner, D.A., Yarbrough, T.L.
Publicado no Clin Nucl Med (2015)

Quantitative lymph node burden as a ‘very-high-risk’ factor identifying head and neck cancer patients benefiting from postoperative chemoradiation

Por Zumsteg, Z S, Luu, M, Kim, S, Tighiouart, M, Mita, A, Scher, K S, Lu, D J, Shiao, S L, Mallen-St. Clair, J, Ho, A S
Publicado no Ann Oncol (2019)

Cost-effectiveness of sentinel lymph node biopsy vs inguinofemoral lymphadenectomy in women with vulval cancer

Por Sutton, A J, Barton, P, Sundar, S, Meads, C, Rosenthal, A N, Baldwin, P, Khan, K, Roberts, T E
Publicado em 2013

New models and online calculator for predicting non-sentinel lymph node status in sentinel lymph node positive breast cancer patients

Por Kohrt, Holbrook E, Olshen, Richard A, Bermas, Honnie R, Goodson, William H, Wood, Douglas J, Henry, Solomon, Rouse, Robert V, Bailey, Lisa, Philben, Vicki J, Dirbas, Frederick M, Dunn, Jocelyn J, Johnson, Denise L, Wapnir, Irene L, Carlson, Robert W, Stockdale, Frank E, Hansen, Nora M, Jeffrey, Stefanie S
Publicado em 2008

Results of resection in non-oat cell carcinoma of the lung with mediastinal lymph node metastases.

Por Martini, N, Flehinger, B J, Zaman, M B, Beattie, E J
Publicado em 1983

Progressive genetic aberrations detected by comparative genomic hybridization in squamous cell cervical cancer

Por Allen, D G, White, D J, Hutchins, A-M, Scurry, J P, Tabrizi, S N, Garland, S M, Armes, J E
Publicado em 2000

The 21-gene recurrence score assay impacts adjuvant therapy recommendations for ER-positive, node-negative and node-positive early breast cancer resulting in a risk-adapted change in chemotherapy use

Por Eiermann, W., Rezai, M., Kümmel, S., Kühn, T., Warm, M., Friedrichs, K., Schneeweiss, A., Markmann, S., Eggemann, H., Hilfrich, J., Jackisch, C., Witzel, I., Eidtmann, H., Bachinger, A., Hell, S., Blohmer, J.
Publicado em 2013

Expression of lymphocyte homing receptor antigen in non-Hodgkin's lymphoma.

Por Picker, L. J., Medeiros, L. J., Weiss, L. M., Warnke, R. A., Butcher, E. C.
Publicado em 1988

Occult Metastases in Lymph Nodes Predict Survival in Resectable Non–Small-Cell Lung Cancer: Report of the ACOSOG Z0040 Trial

Por Rusch, Valerie W., Hawes, Debra, Decker, Paul A., Martin, Sue Ellen, Abati, Andrea, Landreneau, Rodney J., Patterson, G. Alexander, Inculet, Richard I., Jones, David R., Malthaner, Richard A., Cohen, Robbin G., Ballman, Karla, Putnam, Joe B., Cote, Richard J.
Publicado em 2011